Wird geladen...
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
Purpose: Serous adenocarcinoma is a rare, aggressive histologic subtype of endometrial cancer with a high rate of recurrence and a poor prognosis. The optimal adjuvant treatment for early-stage patients is unclear. Our objective was to evaluate the outcomes of stage IA serous endometrial cancers onl...
Gespeichert in:
| Veröffentlicht in: | Cureus |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cureus
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267614/ https://ncbi.nlm.nih.gov/pubmed/30524915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3387 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|